Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

This article explores two pressing health issues: the controversy surrounding weight loss injections given to teenagers and the poignant story of a man choosing assisted dying. Read more...

Recent business news covers mortgage implications after house destruction, wealth-building strategies, prescription drug price cuts, and the rise and fall of Forever 21. Read more...

Sikorsky Australia lands a big helicopter deal, a trading platform touts AI, Hims & Hers faces challenges, and Seasalt Cornwall offers denim discounts. Read more...

This week in health: a study on postpartum depression and brain changes, the risks of overhydration, and the potential pitfalls of weight-loss drugs like Ozempic. Plus, a ruling on cosmetic surgery. Read more...

Wes Streeting faces NHS challenges with a three-point plan and calls for retailer accountability after a teen bought weight-loss drugs. Starmer's peace plan also emerges. Read more...